Abstracts of the Lectures and Posters of the
21st Scientific Congress of the Austrian Pharmaceutical Society (ÖPhG),
April 16th–18th 2009, Vienna, Austria
Short Lectures
SL-01
New Selectors Based on Ligand-Exchange for Enantioseparation by Capillary Electrophoresis
M. G. Schmid, H. Hödl, G. Gübitz
Abstract (pdf)
SL-02
HPLC-ESI-MS/MS Assay for Quantitative Metabolic Profiling in Fermentation Broths from β–Lactam Antibiotics Production
M. Lämmerhofer, S. Schiesel, B. Preinerstorfer, W. Lindner
Abstract (pdf)
SL-03
How to Deal with Ion Suppression – the Foe of HPLC-MS/MS
C. Seger, A. Griesmacher
Abstract (pdf)
SL-04
Targeted Delivery of siRNA to Tumor Cells with Designed Ankyrin Repeat Protein Nanocomplexes
J. Winkler, U. Zangemeister-Wittke
Abstract (pdf)
SL-05
Discovery of Chemosensitizing Flavonoids from Eriobotrya japonica Using in silico and HPLC-SPE-NMR Techniques
P. H. Pfisterer, P. Schneider, A. Rudy, J. M. Rollinger, A. M. Vollmar, H. Stuppner
Abstract (pdf)
SL-06
LC-MS-MS Can Distinguish Between Toxic and Non-Toxic Pyrrolizidine Alkaloids in Plants
J. N. Eloff, M. Rösemann
Abstract (pdf)
SL-07
Speeding Up Pharmaceutical U-HPLC Method Development with an Integrated, Ultrafast Automated Method Scouting Solution
H. Herrmann, S. Ghirlanda, F. Steiner, R. Swart
Abstract (pdf)
SL-08
UPLC Analysis of Herbal Plant Extracts
H. U. Kuffner
Abstract (pdf)
SL-09
Increased Skin Permeation of Acyclovir by Incorporation into Chitosan-Tripolyphosphate Nanoparticles
A. Hasanovic, C. Valenta
Abstract (pdf)
SL-10
Cyclodextrins as Natural Co-Stabilising Agents in Submicron Emulsions
V. Klang, C. Valenta
Abstract (pdf)
SL-11
An Acoustically-Driven Biochip: Particle-Cell Interactions Under Physiological Flow Conditions
C. Fillafer, G. Ratzinger, J. Neumann, S. Dissauer, M. Wirth, F. Gabor, M. Schneider
Abstract (pdf)
SL-12
Pluronic® F-68 Enhances the Nanoparticle-Cell Interaction
V. Kerleta, I. Andrlik, M. Schneider, T. Franke, M. Wirth, F. Gabor
Abstract (pdf)
SL-13
Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin
S. M. Krasteva, L. Krenn
Abstract (pdf)
SL-14
Using Multiple Approaches in Docking Pose Evaluation – Application to the GABAA Receptor
L. Richter, M. Ernst, W. Sieghart, G. F. Ecker
Abstract (pdf)
SL-15
Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research
K. J. Mobbs, N. Faust
Abstract (pdf)
SL-16
Improved “General Unknown” Drug Screening Using GCxGCqMS
S. Böhme, M. Böttcher
Abstract (pdf)
SL-17
Inside the Brain: Fragrance Effects on Human Attention
S. M. Friedl, E. Laistler, E. Moser, E. Heuberger
Abstract (pdf)
SL-18
Behavioral and Endocrine Effects of Essential Oils in Humans
I. Stappen, M. Höferl, E. Heuberger
Abstract (pdf)
SL-19
Evaluation of a Blood-Brain Barrier in vitro Model Based on Primary Rat Cells
W. Neuhaus, E. Subileau, C. Chesne, D. Gruber, S. Tögel, W. Klepal, C. R. Noe
Abstract (pdf)
SL-20
Identification of Privileged Atom-Types in Substrates of the ABC-Transporter ABCB1 (P-gp) by Random Forest Classification
M. A. Demel, O. Krämer, P. Ettmayer, E. E. J. Haaksma, G. F. Ecker
Abstract (pdf)
SL-21
Cells “Feel” Their Surroundings – Implications for Biomedicine and Drug Delivery
L. Neutsch, I. C. Gebeshuber, F. Aumayr, F. Gabor
Abstract (pdf)
SL-22
Influence of Microplate Mixing on Binding Assays
C. Fillafer, R. Nowotny, M. Wirth, F. Gabor
Abstract (pdf)
SL-23
Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting
V. E. Plattner, F. Gabor, G. Borchard, M. Wirth
Abstract (pdf)
SL-24
Gadolinium-labeled PLGA Nanoparticles for Magnetic Resonance Imaging
G. Ratzinger, P. Agrawal, M. Wirth, W. Körner, K. Nicolay, F. Gabor
Abstract (pdf)
SL-25
Antiasthmatic Compounds Isolated from Antiasthmatic “JAMU” Ingredient Legundi Leaves (Vitex trifolia L.)
S. Wahyuono, G. Alam, Z. Ikawati, H. Timmerman, K. Maeyama
Abstract (pdf)
SL-26
Falcarinol Content in Carrot Genotypes Determined by LC-MS
V. Getzinger, E. M. Pferschy-Wenzig, O. Kunert, K. Woelkart, J. Zahrl, R. Bauer
Abstract (pdf)
SL-27
Reverse Chemical Proteomics in Drug Discovery
M. Gotsbacher, P. Karuso
Abstract (pdf)
SL-28
Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats
K. Wölkart, R. Frye, H. Derendorf, R. Bauer, V. Butterweck
Abstract (pdf)
SL-29
Expression of Organic Anion Transporter Polypeptides (OATPs) in Human Breast Carcinoma
K. Wlcek, M. Svoboda, T. Thalhammer, W. Jäger
Abstract (pdf)
SL-30
Expression of Sulfotransferases and Sulfatases in Human Breast Cancer: Impact on Resveratrol Metabolism
M. Miksits, K. Wlcek, M. Svoboda, T. Thalhammer, W. Jäger
Abstract (pdf)
SL-31
Austrian Red Wine Samples Reveal Enhanced Activity of the Enzyme Endothelial Nitric Oxide Synthase
O. Donath, R. Eder, G. Reznicek, V. M. Dirsch
Abstract (pdf)
SL-32
Virtual and Real Screening of Natural Products to Find Effective Modulators of Protein Tyrosine Phosphatase PTP1B
R. R. Baumgartner, T. M. Steindl, D. Schuster, J. M. Rollinger, G. Wolber, H. Stuppner, A. G. Atanasov, E. H. Heiss, V. M. Dirsch
Abstract (pdf)
